tiprankstipranks
Trending News
More News >
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Blogger Opinions & Sentiment

Compare
640 Followers

Blogger Sentiment

Bullish: 80.00%
Sector Average
Bullish
MLTX Blogger sentiment is based on 6 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
80% SeekingAlpha
20% MotleyFool
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal
SeekingAlpha
2 Small-Cap Biotech Stocks Well Positioned for a Breakout
MotleyFool
MoonLake Immunotherapeutics: Maintaining A Small Holding
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any
Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Article
Follow

FAQ

What do Seeking Alpha bloggers think of MLTX?
Seeking Alpha’s Terry Chrisomalis has a Bullish Sentiment.
    What do Motley Fool contributors think of MLTX?
    Currently there's no blogger sentiment for MLTX.
    What Is MLTX’s Blogger Sentiment?
    MLTX’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for MLTX?
      The most recent blogger prediction for MLTX was made by Terry Chrisomalis, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          MRKMerck & Company
          NVONovo Nordisk
          BMYBristol-Myers Squibb
          CRSPCrispr Therapeutics AG
          VKTXViking Therapeutics